Skip to content
Recall Observatory FDA recall evidence

Drug product

VILAMIT MB (118 mg methenamine, 36 mg phenyl salicylate, 40.8 mg sodium phosphate monobasic, 10.0 mg methylene blue and 0.12 mg hyoscyamine sulfate), Rx Only, 100 Capsules per Bottle, Manufactured for: Vilvet Pharmaceuticals Inc., Chester Springs, PA 18425, NDC 71186-002-35.

D-1487-2020

July 24, 2020

Class II

Product summary

Firm
Vilvet Pharmaceuticals Inc.
Event
Event 86069
Status
Terminated
Classification
Class II
Quantity
11,640 bottles
Official record key
drug-enforcement:D-1487-2020

Official wording

Reason: cGMP deviations

Code information: LOT M824H18-1 EXP 08/20 LOT M824J18-1 EXP 09/20 LOT M824L18-1 EXP 11/20 LOT M824A19-1 EXP 01/21 LOT M824C19-1 EXP 03/21 LOT M824G19-1 EXP 07/21

Distribution pattern: Nationwide within the US

Derived failure modes

  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    cGMP deviations